Type 1 diabetes is increasing at a rate of roughly 2% to 3% per year globally, and that pace accelerated sharply during the COVID-19 pandemic. The rise is real, not simply an artifact of better diagnosis, and researchers point to a web of environmental shifts rather than any single cause. Genetics still account for about 80% of who is susceptible, but genes don’t change fast enough to explain a decades-long upward trend. Something in the environment is pulling the trigger more often.
How Fast Rates Are Climbing
Global incidence rose by 2.4% in the most recent year tracked by the International Diabetes Federation. In lower-income countries, the total number of people living with type 1 diabetes jumped 20% between 2021 and 2025, from 1.8 million to 2.1 million. That spike partly reflects better survival and diagnosis in places that previously undercounted cases, but it also reflects genuinely more people developing the disease.
The COVID-19 pandemic made the trend impossible to ignore. A large meta-analysis published in JAMA Network Open found that childhood type 1 diabetes diagnoses were 16% higher in the first year of the pandemic and 28% higher in the second year, compared to the year before. That far outpaces the usual 2% to 3% annual climb. Whether SARS-CoV-2 directly triggers the autoimmune process or whether pandemic-era changes in diet, activity, and infection patterns played a role is still being sorted out.
Genetics Set the Stage, Environment Lights the Match
A 2025 Swedish nationwide cohort study estimated the heritability of type 1 diabetes at 0.83, meaning about 83% of the variation in who develops the disease comes down to genetic factors. That number has stayed remarkably stable over decades of observation. But here’s the key finding: known environmental factors like maternal smoking during pregnancy and childhood obesity explain less than 10% of the increasing incidence. The genetic blueprint hasn’t changed, yet more people are getting sick. That gap points to environmental exposures researchers haven’t fully identified or measured yet.
Nearly half of all type 1 diabetes cases are now diagnosed in adulthood, overturning the old assumption that this is purely a childhood disease. The condition was once called “juvenile diabetes” for that reason. Adult-onset cases are harder to recognize because they’re often initially misdiagnosed as type 2 diabetes, which means part of the apparent rise in adults may reflect improved awareness. But the pediatric increase is well documented and clearly not a diagnostic artifact.
The Hygiene Hypothesis
One of the most studied explanations is that modern cleanliness has backfired. The hygiene hypothesis proposes that children in industrialized countries encounter fewer bacteria, parasites, and other microbes during early life, and that this lack of microbial exposure leaves the immune system poorly calibrated. Without enough real threats to practice on, the immune system is more likely to turn against the body’s own tissues, including the insulin-producing cells of the pancreas.
The biological mechanisms behind this idea involve specific immune pathways. Early microbial exposure appears to stimulate regulatory immune cells that act as a brake on autoimmune reactions. It also activates certain receptors on immune cells that help distinguish genuine threats from the body’s own proteins. When those training experiences are missing, the brake system doesn’t develop properly. Countries with the highest sanitation standards, particularly in Scandinavia, consistently report the highest rates of type 1 diabetes, which fits this pattern.
Viral Infections as Triggers
Certain viruses, particularly a family called enteroviruses, appear capable of triggering the autoimmune destruction of insulin-producing cells in people who are already genetically vulnerable. Coxsackievirus B strains are the most heavily implicated. These common viruses can infect cells in the pancreas, and the immune response they provoke sometimes spills over into an attack on healthy tissue.
Several mechanisms may be at work. The virus can cause direct inflammation in the pancreas, activating nearby immune cells that then mistakenly target insulin-producing cells. It can also disturb the immune system’s tolerance, the process by which the body learns to leave its own cells alone. In some cases, the virus may persist in pancreatic tissue at low levels, keeping the immune attack going long after the initial infection seems to have cleared. A multivalent vaccine targeting all six coxsackievirus B strains has shown promise in animal studies, successfully preventing virus-induced diabetes in mice, though human trials are still in progress.
Gut Bacteria and Intestinal Health
Children who go on to develop type 1 diabetes show measurable differences in their gut bacteria before the disease appears. Studies using genetic sequencing of stool samples have found that children with diabetes-related autoantibodies carry a higher ratio of one major bacterial group (Bacteroidetes) relative to another (Firmicutes), along with lower overall bacterial diversity. Specific species, including Bacteroides dorei and Bacteroides vulgatus, accumulate at higher levels in children at risk.
What’s missing matters too. Bacteria that produce short-chain fatty acids, particularly butyrate, are consistently reduced in people with type 1 diabetes. These fatty acids serve as fuel for the cells lining the intestine and help maintain the gut barrier. When that barrier weakens, intestinal permeability increases, allowing bacterial fragments and food proteins to cross into the bloodstream where they can provoke immune reactions. Children with type 1 diabetes have measurably higher intestinal permeability than healthy children. Beneficial bacteria like Lactobacillus and Bifidobacterium species, which support gut barrier function, are also reduced at the time of diagnosis.
Some gut bacteria may even directly mimic pancreatic proteins. Researchers have identified bacterial protein fragments that closely resemble a key protein found on insulin-producing cells. In mouse models, these mimics activated the very immune cells responsible for destroying pancreatic tissue. This molecular resemblance could help explain how shifts in gut bacteria translate into autoimmune attacks on the pancreas.
Vitamin D and Early Nutrition
Low vitamin D levels have been linked to higher type 1 diabetes risk, and the geography of the disease supports this connection: rates are highest in northern countries with limited winter sunlight. Observational studies suggest that early vitamin D supplementation at standard doses of 400 IU per day or less may not reduce risk, but doses of 2,000 IU per day and higher appear to have a strong protective effect. Most current recommendations fall somewhere in between those ranges, in a dose window that hasn’t been well studied for diabetes prevention specifically.
Vitamin D influences immune regulation in ways that parallel the hygiene hypothesis. It helps promote the same regulatory immune cells that keep autoimmune responses in check. Widespread vitamin D insufficiency, driven by more time indoors, increased sunscreen use, and dietary changes, could be contributing to the rising trend.
Environmental Chemicals
Persistent organic pollutants, chemicals that linger in the environment and accumulate in body fat, are emerging as another potential contributor. A study examining youth with type 1 diabetes found that higher blood levels of several pollutants were associated with roughly double the odds of having the disease. DDE (a breakdown product of the pesticide DDT), trans-nonachlor (a component of the pesticide chlordane), and PCB-153 (an industrial chemical banned decades ago but still present in the food chain) all showed statistically significant associations. These chemicals are known to interfere with immune function, though the exact pathways connecting them to pancreatic autoimmunity are still being mapped.
Why No Single Explanation Is Enough
The rise in type 1 diabetes almost certainly results from multiple environmental changes happening simultaneously in populations that carry genetic susceptibility. Cleaner environments may leave immune systems poorly trained. Shifts in gut bacteria may weaken intestinal barriers. Viral infections may provide the final push. Low vitamin D may remove a layer of immune protection. Chemical exposures may add further immune disruption. Each factor alone might increase risk modestly, but layered together in a modern industrialized lifestyle, they appear to be driving a steady, measurable increase in a disease that was once far less common.
The stable heritability over time tells an important story: the genetic contribution hasn’t changed, which means the environment is doing the heavy lifting in explaining the trend. Identifying which environmental factors matter most, and which are modifiable, is the central challenge in slowing the rise.